10.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com
Earnings call transcript: Ocular Therapeutix Q3 2025 sees mixed results, stock dips - Investing.com
Ocular Therapeutix: Q3 Earnings Snapshot - KVUE
Ocular Therapeutix Inc. Q3 Loss Increases, Misses Estimates - Nasdaq
Ocular Therapeutix completes randomization target for wet AMD drug trial - Investing.com
Earnings Flash (OCUL) Ocular Therapeutix, Inc. Reports Q3 Revenue $14.5M, vs. FactSet Est of $14.6M - MarketScreener
OCULAR THERAPEUTIX, INC SEC 10-Q Report - TradingView
Ocular Therapeutix Reports Third Quarter 2025 Financial Results and Business Highlights - TradingView
Ocular TherapeutixSOL-R Trial On Track For Topline Data In 1H 2027 - TradingView
Multi asset correlation models including Ocular Therapeutix Inc.July 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Ocular Therapeutix Advances AXPAXLI™ Development in Wet AMD with SOL-R Trial Milestone and Upcoming Data in 2027 - Quiver Quantitative
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Ocular Therapeutix (NASDAQ: OCUL) hits 555 SOL-R randomizations; topline data planned 1H 2027 - Stock Titan
Will Ocular Therapeutix Inc. stock see insider buyingJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com
Short interest data insights for Ocular Therapeutix Inc.Trade Exit Report & Safe Entry Zone Identification - newser.com
Can Ocular Therapeutix Inc. (0OT) stock beat analyst consensusCEO Change & Safe Capital Preservation Plans - newser.com
Why analysts upgrade Ocular Therapeutix Inc. stockQuarterly Portfolio Review & Fast Gain Stock Tips - newser.com
What institutional flow reveals about Ocular Therapeutix Inc.July 2025 Snapshot & Daily Risk Controlled Trade Plans - newser.com
What RSI levels show for Ocular Therapeutix Inc. (0OT) stockWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - newser.com
Is Ocular Therapeutix Inc. stock undervalued vs historical averages2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com
Can Ocular Therapeutix Inc. hit a new high this monthJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Ocular Therapeutix Inc (OCUL) Q3 2025 Earnings Report Preview: What To Expect - GuruFocus
Hydrogel-Based Drug Delivery System Market Set to Witness - openPR.com
Will Ocular Therapeutix Inc. stock go up soonInflation Watch & Low Risk High Win Rate Picks - newser.com
Why Ocular Therapeutix Inc. stock appeals to analystsJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Detecting support and resistance levels for Ocular Therapeutix Inc.Trade Signal Summary & Entry Point Strategy Guides - newser.com
How to interpret RSI for Ocular Therapeutix Inc. stock2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
What Ocular Therapeutix (OCUL)'s SOL-1 Trial Milestone and Capital Raise Mean for Shareholders - Sahm
Is Ocular Therapeutix Inc. stock oversold or undervalued2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
Real time scanner hits for Ocular Therapeutix Inc. explainedAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
How to recover losses in Ocular Therapeutix Inc. stockJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com
How Ocular Therapeutix Inc. (0OT) stock responds to job market shiftsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Is Ocular Therapeutix Inc. (0OT) stock positioned for digital growth eraWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):